The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Open accessAbstract
Bruton's tyrosine kinase (BTK) was initially discovered as a critical mediator of B cell receptor signaling in the development and functioning of adaptive immunity. Growing evidence also suggests multiple roles for BTK in mononuclear cells of the innate immune system, especially in dendritic cells and macrophages. For example, BTK has been shown to function in Toll-like receptor-mediated recognition of infectious agents, cellular maturation and recruitment processes, and Fc receptor signaling. Most recently, BTK was additionally identified as a direct regulator of a key innate inflammatory machinery, the NLRP3 inflammasome. BTK has thus attracted interest not only for gaining a more thorough basic understanding of the human innate immune system but also as a target to therapeutically modulate innate immunity. We here review the latest developments on the role of BTK in mononuclear innate immune cells in mouse versus man, with specific emphasis on the sensing of infectious agents and the induction of inflammation. Therapeutic implications for modulating innate immunity and critical open questions are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gray, P., Dunne, A., Brikos, C., Jefferies, C. A., Doyle, S. L., & O'Neill, L. A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508892200 · Cited by 201
RetractedA small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
BRUTON, O. C. (1952) · Pediatrics · doi:10.1542/peds.9.6.722 · Cited by 1,492
Vetrie, D., Vořechovský, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarström, L., Kinnon, C., Levinsky, R., Bobrow, M., et al. (1993) · Nature · doi:10.1038/361226a0 · Cited by 1,461
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID Mice
Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., et al. (1993) · Science · doi:10.1126/science.8332901 · Cited by 856
Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment
Nagai, Y., Garrett, K. P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K., & Kincade, P. W. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.008 · Cited by 842
X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients
Winkelstein, J. A., Marino, M. C., Lederman, H. M., Jones, S. M., Sullivan, K., Burks, A. W., Conley, M. E., Cunningham-Rundles, C., & Ochs, H. D. (2006) · Medicine · doi:10.1097/01.md.0000229482.27398.ad · Cited by 639
Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Gunderson, A. J., Kaneda, M. M., Tsujikawa, T., Nguyen, A. V., Affara, N. I., Ruffell, B., Gorjestani, S., Liudahl, S. M., Truitt, M., Olson, P., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0827 · Cited by 486
Ito, M., Shichita, T., Okada, M., Komine, R., Noguchi, Y., Yoshimura, A., & Morita, R. (2015) · Nature Communications · doi:10.1038/ncomms8360 · Cited by 412
The B-cell receptor signaling pathway as a therapeutic target in CLL
Woyach, J. A., Johnson, A. J., & Byrd, J. C. (2012) · Blood · doi:10.1182/blood-2012-02-362624 · Cited by 412
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Di Paolo, J. A., Huang, T., Balazs, M., Barbosa, J., Barck, K. H., Bravo, B. J., Carano, R. A. D., Darrow, J., Davies, D. R., DeForge, L. E., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.481 · Cited by 340
Caspase‐4 mediates non‐canonical activation of the NLRP3 inflammasome in human myeloid cells
Schmid‐Burgk, J. L., Gaidt, M. M., Schmidt, T., Ebert, T. S., Bartok, E., & Hornung, V. (2015) · European Journal of Immunology · doi:10.1002/eji.201545523 · Cited by 315
The Inflammasomes and Autoinflammatory Syndromes
Broderick, L., De Nardo, D., Franklin, B. S., Hoffman, H. M., & Latz, E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040431 · Cited by 295
Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., & O'Neill, L. A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301484200 · Cited by 292
Self-citationIbrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
Kamel, S., Horton, L., Ysebaert, L., Levade, M., Burbury, K., Tan, S., Cole-Sinclair, M., Reynolds, J., Filshie, R., Schischka, S., et al. (2015) · Leukemia · doi:10.1038/leu.2014.247 · Cited by 231
Bruton’s Tyrosine Kinase Is Required for TLR2 and TLR4-Induced TNF, but Not IL-6, Production
Horwood, N. J., Page, T. H., McDaid, J. P., Palmer, C. D., Campbell, J., Mahon, T., Brennan, F. M., Webster, D., & Foxwell, B. M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3635 · Cited by 203
BTKbase: the mutation database for X-linked agammaglobulinemia
Väliaho, J., Smith, C. I. E., & Vihinen, M. (2006) · Human Mutation · doi:10.1002/humu.20410 · Cited by 196
The structure of rotational bands in alpha-cluster nuclei
Bijker, R. (2015) · EPJ Web of Conferences · doi:10.1051/epjconf/20159301011 · Cited by 180
Herbst, S., Shah, A., Mazon Moya, M., Marzola, V., Jensen, B., Reed, A., Birrell, M. A., Saijo, S., Mostowy, S., Shaunak, S., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404556 · Cited by 176
Wiczer, T. E., Levine, L. B., Brumbaugh, J., Coggins, J., Zhao, Q., Ruppert, A. S., Rogers, K., McCoy, A., Mousa, L., Guha, A., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009720 · Cited by 163
Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
Lee, K.-G., Xu, S., Kang, Z.-H., Huo, J., Huang, M., Liu, D. X., Takeuchi, O., Akira, S., & Lam, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119238109 · Cited by 150
Liu, X., Pichulik, T., Wolz, O., Dang, T., Stutz, A., Dillen, C. A., Garcia, M. D., Kraus, H., Dickhöfer, S., Daiber, E., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.017 · Cited by 141
Self-citationJongstra‐Bilen, J., Cano, A. P., Hasija, M., Xiao, H., Smith, C. I. E., & Cybulsky, M. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.288 · Cited by 138
Wahl, M. I., Fluckiger, A.-C., Kato, R. M., Park, H., Witte, O. N., & Rawlings, D. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11526 · Cited by 138
Honda, F., Kano, H., Kanegane, H., Nonoyama, S., Kim, E. S., Lee, S., Takagi, M., Mizutani, S., & Morio, T. (2012) · Nature Immunology · doi:10.1038/ni.2234 · Cited by 123
Fiedler, K., Sindrilaru, A., Terszowski, G., Kókai, E., Feyerabend, T. B., Bullinger, L., Rodewald, H.-R., & Brunner, C. (2010) · Blood · doi:10.1182/blood-2010-04-281170 · Cited by 121
Self-citationMurthy, P., Durco, F., Miller-Ocuin, J. L., Takedai, T., Shankar, S., Liang, X., Liu, X., Cui, X. D., Sachdev, U., Rath, D., et al. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.161 · Cited by 114
Self-citationPing, L., Ding, N., Shi, Y., Feng, L., Li, J., Liu, Y., Lin, Y., Shi, C., Wang, X., Pan, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16836 · Cited by 101
The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation
Volmering, S., Block, H., Boras, M., Lowell, C. A., & Zarbock, A. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.011 · Cited by 98 · cited 1×
“In mice, Btk deficiency also correlated with reduced monocyte/macrophage numbers (33) but favored granulopoiesis (34, 35).”
BackgroundRegulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3
Kawakami, Y., Inagaki, N., Salek‐Ardakani, S., Kitaura, J., Tanaka, H., Nagao, K., Kawakami, Y., Xiao, W., Nagai, H., Croft, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509784103 · Cited by 92
Neutropenia in X-Linked Agammaglobulinemia
Farrar, J. E., Rohrer, J., & Conley, M. E. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0188 · Cited by 89
Sochorová, K., Horváth, R., Rožková, D., Litzman, J., Bartůňková, J., Šedivá, A., & Špíšek, R. (2006) · Blood · doi:10.1182/blood-2006-07-037960 · Cited by 80
Williams, A. M., Baran, A. M., Meacham, P. J., Feldman, M. M., Valencia, H. E., Newsom-Stewart, C. M., Gupta, N. E., Janelsins, M. C., Barr, P. M., & Zent, C. S. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1347931 · Cited by 76
Tyrosine Kinase Btk Is Required for NK Cell Activation
Bao, Y., Zheng, J. H., Han, C., Jin, J., Han, H., Liu, Y., Lau, Y., Tu, W., & Cao, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372425 · Cited by 73
Garstkiewicz, M., Strittmatter, G. E., Grossi, S., Sand, J., Fenini, G., Werner, S., French, L. E., & Beer, H. (2017) · European Journal of Immunology · doi:10.1002/eji.201646665 · Cited by 72 · cited 12×
“Whether BTK also plays a role in the alternative NLRP3 inflammasome dependent on caspase-11 remains to be investigated.”
BackgroundInfluentialBruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
Lougaris, V., Baronio, M., Vitali, M. A., Tampella, G., Cattalini, M., Tassone, L., Soresina, A., Badolato, R., & Plebani, A. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1085 · Cited by 69
Vijayan, V., Baumgart‐Vogt, E., Naidu, S., Qian, G., & Immenschuh, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003631 · Cited by 67
Maurya, N., Gujar, R., Gupta, M., Yadav, V., Verma, S., & Sen, P. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400395 · Cited by 66
Taneichi, H., Kanegane, H., Sıra, M. M., Futatani, T., Agematsu, K., Sako, M., Kaneko, H., Kondo, N., Kaisho, T., & Miyawaki, T. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.10.005 · Cited by 66
Melcher, M., Unger, B., Schmidt, U., Rajantie, I., Alitalo, K. K., & Ellmeier, W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8048 · Cited by 65
Grassilli, E., Pisano, F., Cialdella, A., Bonomo, S., Missaglia, C., Cerrito, M. G., Masiero, L., Ianzano, L., Giordano, F., Cicirelli, V., et al. (2016) · Oncogene · doi:10.1038/onc.2015.504 · Cited by 65
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Eifert, C., Wang, X., Kokabee, L., Kourtidis, A., Jain, R., Gerdes, M. J., & Conklin, D. S. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22091 · Cited by 64
Li, W., Su, Y.-K., Lin, C., Chao, T.-Y., Huang, S.-P., Huynh, T.-T., Jan, H.-J., Whang‐Peng, J., Chiou, J.-F., Wu, A. T. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11572 · Cited by 55
Marron, T. U., Martínez‐Gallo, M., Yu, J. E., & Cunningham‐Rundles, C. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.009 · Cited by 54
Al, A., Kanegane, H., Miyawaki, T., & Mm, V. (2003) · PubMed · Cited by 54
Semaan, N., Alsaleh, G., Gottenberg, J., Wachsmann, D., & Sibilia, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3485 · Cited by 51
Btk is a positive regulator in the TREM-1/DAP12 signaling pathway
Ormsby, T., Schlecker, E., Ferdin, J., Tessarz, A. S., Angelisová, P., Köprülü, A. D., Borte, M., Warnatz, K., Schulze, I., Ellmeier, W., et al. (2011) · Blood · doi:10.1182/blood-2010-11-317016 · Cited by 49
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer
Kokabee, L., Wang, X., Sevinsky, C. J., Wang, W. L. W., Cheu, L. A., Chittur, S. V., Karimipoor, M., Tenniswood, M., & Conklin, D. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1078023 · Cited by 48
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cells
Natarajan, G. K., Terrazas, C. A., Oghumu, S., Varikuti, S., Dubovsky, J. A., Byrd, J. C., & Satoskar, A. R. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1057385 · Cited by 47
Stadler, N., Hasibeder, A., Lopez, P. A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.152017 · Cited by 47
Singhal, E., Kumar, P., & Sen, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271247 · Cited by 40
Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.
Wang, J. D., Chen, X. Y., Ji, K. W., & Tao, F. (2016) · Europe PMC (PubMed Central) · Cited by 37
Cavaliere, F. M., Prezzo, A., Bilotta, C., Iacobini, M., & Quinti, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175961 · Cited by 36
TLR signaling and effector functions are intact in XLA neutrophils
Marron, T. U., Rohr, K., Martínez‐Gallo, M., Yu, J. E., & Cunningham‐Rundles, C. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.06.011 · Cited by 35
Neutropenia associated with X-linked agammaglobulinaemia.
Kozlowski, C., & Evans, D. I. K. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.5.388 · Cited by 32
Mirsafian, H., Ripen, A. M., Leong, W.-M., Chear, C. T., Mohamad, S. B., & Merican, A. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-06342-5 · Cited by 31
General Strategies in Inflammasome Biology
Dubois, H., Wullaert, A., & Lamkanfi, M. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_1 · Cited by 26
A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells
Natarajan, G. K., Oghumu, S., Terrazas, C. A., Varikuti, S., Byrd, J. C., & Satoskar, A. R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1151592 · Cited by 25
X‐chromosome‐linked immune‐deficient mice have B‐1b cells
Riggs, J. E., Howell, K. F., Matechin, B., Matlack, R., Pennello, A. L., & Chiasson, R. J. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01624.x · Cited by 19
c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor
Gujar, R., Maurya, N., Yadav, V., Gupta, M., Arora, S., Khatri, N., & Sen, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600104 · Cited by 18
Cited by
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Yang, M., Li, J., Gu, P., & Fan, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 670
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Roschewski, M., Lionakis, M. S., Sharman, J. P., Roswarski, J., Goy, A., Monticelli, M. A., Roshon, M., Wrzesinski, S. H., Desai, J. V., Zarakas, M. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd0110 · Cited by 357
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Copaescu, A., Smibert, O., Gibson, A., Phillips, E. J., & Trubiano, J. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.001 · Cited by 262
Reich, D. S., Arnold, D. L., Vermersch, P., Bar-Or, A., Fox, R. J., Matta, A., Turner, T., Wallström, E., Zhang, X., Mareš, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00237-4 · Cited by 204
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
Metadata
- Authors
- Weber, A. N. R., Bittner, Z., Liu, X., Dang, T.-M., Radsak, M. P., & Brunner, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2017-11-08
- Volume
- 8
- Pages
- 1454-1454
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2766697888
- Cited by
- 269
- References
- 61
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.